Patents Assigned to Nalpropioin Pharmaceuticals LLC
  • Methods for Treating Visceral Fat Conditions
    Publication number: 20220257591
    Abstract: Disclosed are methods and compositions for treating visceral fat conditions and/or metabolic syndrome using combinations of naltrexone and bupropion.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 18, 2022
    Applicant: Nalpropioin Pharmaceuticals LLC
    Inventor: Gary Tollefson